Brian David - Publications
Affiliations: | 2015- | Medicinal Chemistry and Pharmacognosy | University of Illinois at Chicago, Chicago, IL, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2020 | Lazzara PR, Jain AD, Maldonado AC, Richardson B, Skowron KJ, David BP, Siddiqui Z, Ratia KM, Moore TW. Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors. Acs Medicinal Chemistry Letters. 11: 521-527. PMID 32292559 DOI: 10.1021/Acsmedchemlett.9B00631 | 0.63 | |||
2019 | Lazzara PR, David BP, Ankireddy A, Richardson B, Dye K, Ratia KM, Reddy SP, Moore TW. Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability. Journal of Medicinal Chemistry. PMID 31682434 DOI: 10.1021/Acs.Jmedchem.9B01074 | 0.671 | |||
2019 | Skowron KJ, Booker K, Cheng C, Creed S, David BP, Lazzara PR, Lian A, Siddiqui Z, Speltz TE, Moore TW. Steroid receptor/coactivator binding inhibitors: An update. Molecular and Cellular Endocrinology. 110471. PMID 31163202 DOI: 10.1016/J.Mce.2019.110471 | 0.622 | |||
2018 | Richardson B, Jain AD, Potteti H, Lazzara PR, David BP, Tamatam C, Choma E, Skowron K, Dye K, Siddiqui Z, Wang YT, Krunic A, Reddy S, Moore TW. Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear factor (erythroid-derived 2)-like 2 (NRF2)Inhibitors. Journal of Medicinal Chemistry. PMID 30122040 DOI: 10.1021/Acs.Jmedchem.8B01133 | 0.647 | |||
2018 | David BP, Dubrovskyi O, Speltz TE, Wolff JJ, Frasor J, Sanchez LM, Moore TW. Using Tumor Explants for Imaging Mass Spectrometry Visualization of Unlabeled Peptides and Small Molecules. Acs Medicinal Chemistry Letters. 9: 768-772. PMID 30034616 DOI: 10.1021/Acsmedchemlett.8B00091 | 0.691 | |||
Show low-probability matches. |